Peptides serve as effective drugs in the clinic today. However the inherent drawbacks of peptide structures can limit their efficacy as drugs. To overcome this researchers are developing new methods to create ‘tailor-made’ peptides and proteins with improved pharmacological properties. ***Design of
Design of peptide affinity ligands for S-protein: a comparison of combinatorial and de novo design strategies
✍ Scribed by Divya Chandra, Christopher J. Morrison, James Woo, Steven Cramer…
- Book ID
- 120750565
- Publisher
- Springer
- Year
- 2013
- Tongue
- English
- Weight
- 767 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1381-1991
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Monoclonal anti‐HIV antibody 4E10 (mAb 4E10) is one of the most broadly neutralizing antibodies against HIV, directed against a specific epitope on envelope protein gp41. In the present study, a combinatorial __de novo__ design approach was used for the development of a biomimetic ligan
Rational design and combinatorial chemistry were utilized to search for lead protein L (PpL) mimetics for application as affinity ligands for the purification of antibodies and small fragments, such as Fab and scFv, and as potential diagnostic or therapeutic agents. Inspection of the key structural